1. Home
  2. TRIB vs UTSI Comparison

TRIB vs UTSI Comparison

Compare TRIB & UTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRIB
  • UTSI
  • Stock Information
  • Founded
  • TRIB 1992
  • UTSI 1991
  • Country
  • TRIB Ireland
  • UTSI China
  • Employees
  • TRIB 380
  • UTSI N/A
  • Industry
  • TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • UTSI Telecommunications Equipment
  • Sector
  • TRIB Health Care
  • UTSI Telecommunications
  • Exchange
  • TRIB Nasdaq
  • UTSI Nasdaq
  • Market Cap
  • TRIB 10.7M
  • UTSI 21.2M
  • IPO Year
  • TRIB N/A
  • UTSI 2000
  • Fundamental
  • Price
  • TRIB $0.71
  • UTSI $2.41
  • Analyst Decision
  • TRIB
  • UTSI
  • Analyst Count
  • TRIB 0
  • UTSI 0
  • Target Price
  • TRIB N/A
  • UTSI N/A
  • AVG Volume (30 Days)
  • TRIB 40.9K
  • UTSI 1.6K
  • Earning Date
  • TRIB 05-22-2025
  • UTSI 05-02-2025
  • Dividend Yield
  • TRIB N/A
  • UTSI N/A
  • EPS Growth
  • TRIB N/A
  • UTSI N/A
  • EPS
  • TRIB N/A
  • UTSI N/A
  • Revenue
  • TRIB $59,126,000.00
  • UTSI $10,878,000.00
  • Revenue This Year
  • TRIB $11.63
  • UTSI N/A
  • Revenue Next Year
  • TRIB $10.13
  • UTSI N/A
  • P/E Ratio
  • TRIB N/A
  • UTSI N/A
  • Revenue Growth
  • TRIB N/A
  • UTSI N/A
  • 52 Week Low
  • TRIB $0.48
  • UTSI $1.84
  • 52 Week High
  • TRIB $3.55
  • UTSI $3.22
  • Technical
  • Relative Strength Index (RSI)
  • TRIB 62.34
  • UTSI 53.45
  • Support Level
  • TRIB $0.51
  • UTSI $2.00
  • Resistance Level
  • TRIB $0.57
  • UTSI $2.39
  • Average True Range (ATR)
  • TRIB 0.06
  • UTSI 0.13
  • MACD
  • TRIB 0.02
  • UTSI 0.02
  • Stochastic Oscillator
  • TRIB 97.02
  • UTSI 86.36

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp operates as a telecom infrastructure provider. It develops technology for bandwidth from cloud-based services, mobile, streaming, and other applications. The range of solutions is designed to expand and modernize telecommunications networks through smooth network system integration, lower operating costs, and increased broadband access. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. The company operates in China, India, Japan, Taiwan and other countries.

Share on Social Networks: